Upregulation of miR‑335 exerts protective effects against sepsis‑induced myocardial injury

Long,Xian; Huang,Yongpan; He,Jianbin; Zhang,Xiang; Zhou,Yan; Wei,Yingmin; Tang,Ying; Liu,Lijing

doi:10.3892/mmr.2021.12446

Upregulation of miR‑335 exerts protective effects against sepsis‑induced myocardial injury

Authors:
- Xian Long
- Yongpan Huang
- Jianbin He
- Xiang Zhang
- Yan Zhou
- Yingmin Wei
- Ying Tang
- Lijing Liu
View Affiliations

Affiliations: Department of Clinic, Medicine School, Changsha Social Work College, Changsha, Hunan 410004, P.R. China, Department of Respiratory and Critical Care Medicine, The First People's Hospital of Huaihua, Affiliated to University of South China, Huaihua, Hunan 418000, P.R. China
Published online on: September 17, 2021 https://doi.org/10.3892/mmr.2021.12446
Article Number: 806
Copyright: © Long et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Septicemia is associated with excessive inflammation, oxidative stress and apoptosis, causing myocardial injury that results in high mortality and disability rates worldwide. The abnormal expression of multiple microRNAs (miRNAs/miRs) is associated with more severe sepsis‑induced myocardial injury (SIMI) and miR‑335 has been shown to protect cardiomyocytes from oxidative stress. The present study aimed to investigate the role of miR‑335 in SIMI. An SIMI model was established by cecal ligation and puncture (CLP) in mice. An miRNA‑335 precursor (pre‑miR‑335) was transfected to accelerate miR‑335 expression and an miR‑335 inhibitor (anti‑miR‑335) was used to inhibit miR‑335 expression. CLP or sham surgery was performed on pre‑miR‑335, anti‑miR‑335 and wild‑type mice and miR‑335 expression was determined by reverse transcription‑quantitative PCR. Inflammatory factors (TNF‑α, IL‑6 and IL‑10) and troponin (cTNI), brain natriuretic peptide (BNP), creatine kinase (CK), lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) were assessed using commercial kits. Apoptosis was detected by flow cytometry and cardiac function was assessed using a Langendorff isolated cardiac perfusion system. miR‑335 expression was upregulated and an elevation in inflammatory factors and cTNI, BNP, CK, LDH and AST was observed. Compared with the wild‑type control group, pre‑miR‑335 mice treated with CLP exhibited significantly reduced left ventricular development pressure, maximum pressure increased reduction rates, as well as decreased levels of TNF‑α, IL‑6 and IL‑10, myocardial injury and apoptosis; by contrast, these features were amplified in CLP‑treated anti‑miR‑335 mice. In conclusion, the upregulation of miR‑335 exerted ameliorative effects on myocardial injury following sepsis and may indicate a novel therapeutic intervention for SIMI.

View Figures

View References

1	Gomez E, Vercauteren M, Kurtz B, Ouvrard-Pascaud A, Mulder P, Henry JP, Besnier M, Waget A, Hooft Van Huijsduijnen R, Tremblay ML, et al: Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. J Mol Cell Cardiol. 52:1257–1264. 2012. View Article : Google Scholar : PubMed/NCBI
2	Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J and Huertos-Ranchal MJ: Sepsis-induced cardiomyopathy. Curr Cardiol Rev. 7:163–183. 2011. View Article : Google Scholar : PubMed/NCBI
3	Hochstadt A, Meroz Y and Landesberg G: Myocardial dysfunction in severe sepsis and septic shock: More questions than answers? J Cardiothorac Vasc Anesth. 25:526–535. 2011. View Article : Google Scholar : PubMed/NCBI
4	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
5	Patop IL, Wüst S and Kadener S: Past, present and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI
6	Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P and Wu M: CircRNA: Functions and properties of a novel potential biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
7	Zhelankin AV, Vasiliev SV, Stonogina DA, Babalyan KA, Sharova EI, Doludin YV, Shchekochikhin DY, Generozov EV and Akselrod AS: Elevated Plasma levels of circulating extracellular miR-320a-3p in patients with paroxysmal atrial fibrillation. Int J Mol Sci. 21:34852020. View Article : Google Scholar : PubMed/NCBI
8	Wang L, Wang HC, Chen C, Zeng JM, Wang Q, Zheng L and Yu HD: Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients. Exp Ther Med. 5:1101–1104. 2013. View Article : Google Scholar : PubMed/NCBI
9	Ailawadi S, Wang X, Gu H and Fan GC: Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta. 1852:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
10	Halushka PV, Goodwin AJ and Halushka MK: Opportunities for microRNAs in the crowded field of cardiovascular biomarkers. Annu Rev Pathol. 14:211–238. 2019. View Article : Google Scholar : PubMed/NCBI
11	Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH and Xie LX: Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma. 73:850–854. 2012. View Article : Google Scholar : PubMed/NCBI
12	Wang HJ: Serum miRNA-574-5p: A prognostic predictor of sepsis patients. Shock. 37:263–267. 2012. View Article : Google Scholar : PubMed/NCBI
13	Wang HJ, Deng J, Wang JY, Zhang PJ, Xin Z, Xiao K, Feng D, Jia YH, Liu YN and Xie LX: Serum miRNA-122 levels are related to coagulation disorders in sepsis patients. Clin Chem Lad Med. 52:927–933. 2014.PubMed/NCBI
14	Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, et al: Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med. 42:1096–104. 2014. View Article : Google Scholar : PubMed/NCBI
15	Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 284:29514–29525. 2009. View Article : Google Scholar : PubMed/NCBI
16	Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X and Fan GC: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 94:379–390. 2012. View Article : Google Scholar : PubMed/NCBI
17	Li W, Dong M, Chu L, Feng L and Sun X: MicroRNA-451 relieves inflammation in cerebral ischemia-reperfusion via the Toll-like receptor 4/MyD88/NF-κB signaling pathway. Mol Med Rep. 20:3043–3054. 2019.PubMed/NCBI
18	Kura B, Szeiffova Bacova B, Kalocayova B, Sykora M and Slezak J: Oxidative stress-responsive MicroRNAs in heart injury. Int J Mol Sci. 21:3582020. View Article : Google Scholar : PubMed/NCBI
19	Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 49:841–850. 2010. View Article : Google Scholar : PubMed/NCBI
20	Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z and Fan GC: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion induced cardiac injury. Circulation. 122:1308–1318. 2010. View Article : Google Scholar : PubMed/NCBI
21	Yu Y, Gao R, Kaul Z, Li L, Kato Y, Zhang Z, Groden J, Kaul SC and Wadhwa R: Loss-of-function screening to identify miRNAs involved in senescence: Tumor suppressor activity of miRNA-335 and its new arget CARF. Sci Rep. 6:301852016. View Article : Google Scholar : PubMed/NCBI
22	Ge C, Liu J and Dong S: miRNA-214 protects sepsis-induced myocardial injury. Shock. 50:112–118. 2018. View Article : Google Scholar : PubMed/NCBI
23	Wang Y, Wang H, Ding Y, Li Y, Chen S, Zhang L, Wu H, Zhou J, Duan K, Wang W, et al: N-peptide of vMIP-II reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer. Int J Oncol. 51:918–930. 2017. View Article : Google Scholar : PubMed/NCBI
24	O'Shea KM, Ananthakrishnan R, Li Q, Quadri N, Thiagarajan D, Sreejit G, Wang L, Zirpoli H, Aranda JF, Alberts AS, et al: The formin, DIAPH1, is a key modulator of myocardial ischemia/reperfusion injury. EBioMedicine. 26:165–174. 2017. View Article : Google Scholar : PubMed/NCBI
25	Togashi Y, Shirakawa J, Okuyama T, Yamazaki S, Kyohara M, Miyazawa A, Suzuki T, Hamada M and Terauchi Y: Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice. Sci Rep. 6:254652016. View Article : Google Scholar : PubMed/NCBI
26	Haak BW, Prescott HC and Wiersinga WJ: Therapeutic potential of the gut microbiota in the prevention and treatment of sepsis. Front Immunol. 9:20422018. View Article : Google Scholar : PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Zhang SB, Lin SY, Liu M, Liu CC, Ding HH, Sun Y, Ma C, Guo RX, Lv YY, Wu SL, et al: CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain. Nat Commun. 10:41192019. View Article : Google Scholar : PubMed/NCBI
29	Liang L, Fu J, Wang S, Cen H, Zhang L, Mandukhail SR, Du L, Wu Q, Zhang P and Yu X: MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1. Acta Pharm Sin B. 10:1036–1046. 2020. View Article : Google Scholar : PubMed/NCBI
30	Gao Y, Zhao H and Li Y: LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis. BMC Musculoskelet Disord. 20:6052019. View Article : Google Scholar : PubMed/NCBI
31	Liang H, Su X, Wu Q, Shan H, Lv L, Yu T, Zhao X, Sun J, Yang R, Zhang L, et al: LncRNA 2810403D21Rik/Mirf promotes ischemic myocardial injury by regulating autophagy through targeting Mir26a. Autophagy. 16:1077–1091. 2020. View Article : Google Scholar : PubMed/NCBI
32	Huang YP, Gao FF, Wang B, Zheng FC, Zhang YM, Chen YC, Huang ZQ, Zheng YS, Zhong SP and Shi GG: N-n-butyl haloperidol iodide inhibits H₂O₂-induced Na+/Ca²+-exchanger activation via the Na+/H+ exchanger in rat ventricular myocytes. Drug Des Devel Ther. 8:1257–1267. 2014.PubMed/NCBI
33	Chistiakov DA, Orekhov AN and Bobryshev YV: Cardiac-specific miRNA in cardiogenesis, heart function and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol. 94:107–121. 2016. View Article : Google Scholar : PubMed/NCBI
34	Bai XY, Ma Y, Ding R, Fu B, Shi S and Chen XM: miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol. 22:1252–1261. 2011. View Article : Google Scholar : PubMed/NCBI
35	Liu Y, Lai P, Deng J, Hao Q, Li X, Yang M, Wang H and Dong B: Micro-RNA335-5p targeted inhibition of sKlotho and promoted oxidativestress-mediated aging of endothelial cells. Biomark Med. 13:457–466. 2019. View Article : Google Scholar : PubMed/NCBI
36	Wu ZJ, Chen YF, Wang HD and Gao FH: Expression of plasma miRNA-497 in children with sepsis-induced myocardial injury and its clinical significance. Zhongguo Dang Dai Er Ke Za Zhi. 20:32–36. 2018.(In Chinese). PubMed/NCBI
37	Wang SM, Liu GQ, Xian HB, Si JL, Qi SX and Yu YP: LcRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 23:4898–4907. 2019.PubMed/NCBI
38	An R, Feng J, Xi C, Xu J and Sun L: miR-146a attenuates sepsis-induced myocardial dysfunction by suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression. Oxid Med Cell Longev. 2018:71630572018. View Article : Google Scholar : PubMed/NCBI
39	Shang X, Li J, Yu R, Zhu P, Zhang Y, Xu J, Chen K and Li M: Sepsis-related myocardial injury is associated with mst1 upregulation, mitochondrial dysfunction and the Drp1/F-actin signaling pathway. J Mol Histol. 50:91–103. 2019. View Article : Google Scholar : PubMed/NCBI
40	Rudiger A and Singer M: The heart in sepsis: From basic mechanisms to clinical management. Curr Vasc Pharmacol. 11:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
41	Reinhart K, Bauer M, Riedemann NC and Hartog CS: New approaches to sepsis: Molecular diagnostics and biomarkers. Clin Microbiol Rev. 25:609–634. 2012. View Article : Google Scholar : PubMed/NCBI
42	Liu Y, Liu L and Zhang J: Protective role of matrine in sepsis-associated cardiac dysfunction through regulating the lncRNA PTENP1/miR-106b-5p axis. Biomed Pharmacother. 134:1111122021. View Article : Google Scholar : PubMed/NCBI
43	Sluijter JP and Doevendans PA: Sepsis-associated cardiac dysfunction is controlled by small RNA molecules. J Mol Cell Cardiol. 97:67–69. 2016. View Article : Google Scholar : PubMed/NCBI
44	Wang H, Bei Y, Shen S, Huang P, Shi J, Zhang J, Sun Q, Chen Y, Yang Y, Xu T, et al: miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 94:43–53. 2016. View Article : Google Scholar : PubMed/NCBI
45	Wu N, Zhang X, Du S, Chen D and Che R: Upregulation of miR-335 ameliorates myocardial ischemia reperfusion injury via targeting hypoxia inducible factor 1-alpha subunit inhibitor. Am J Transl Res. 10:4082–4094. 2018.PubMed/NCBI
46	Joulin O, Petillot P, Labalette M, Lancel S and Neviere R: Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol Res. 56:291–297. 2007. View Article : Google Scholar : PubMed/NCBI
47	Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C and Foti M: Deciphering miRNAs' Action through miRNA Editing. Int J Mol Sci. 20:62492019. View Article : Google Scholar : PubMed/NCBI
48	Agnelli L, Bisognin A, Todoerti K, Manzoni M, Taiana E, Galletti S, Cutrona G, Gaffo E, Bortoluzzi S and Neri A: Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing. Blood Cancer J. 9:212019. View Article : Google Scholar : PubMed/NCBI
49	Huang W: MicroRNAs: Biomarkers, diagnostics, and therapeutics. Methods Mol Biol. 1617:57–67. 2017. View Article : Google Scholar : PubMed/NCBI
50	Moradifard S, Hoseinbeyki M, Ganji SM and Minuchehr Z: Analysis of microRNA and gene expression profiles in Alzheimer's disease: A Meta-analysis approach. Sci Rep. 8:47672018. View Article : Google Scholar : PubMed/NCBI
51	Papaioannou V, Pneumatikos I and Maglaveras N: Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: Current strengths and limitations. Front Physiol. 4:1742013. View Article : Google Scholar : PubMed/NCBI
52	Ruiz-Ortega M, Esteban V and Egido J: The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. Trends Cardiovasc Med. 17:19–25. 2007. View Article : Google Scholar : PubMed/NCBI
53	Frangogiannis NG: Pathophysiology of myocardial infarction. Compr Physiol. 5:1841–1875. 2015. View Article : Google Scholar : PubMed/NCBI
54	Hanna A and Frangogiannis NG: Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther. 34:849–863. 2020. View Article : Google Scholar : PubMed/NCBI
55	Bartekova M, Radosinska J, Jelemensky M and Dhalla NS: Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev. 23:733–758. 2018. View Article : Google Scholar : PubMed/NCBI
56	Bai R, Yin X, Feng X, Cao Y, Wu Y, Zhu Z, Li C, Tu P and Chai X: Corydalis hendersonii Hemsl. Protects against myocardial injury by attenuating inflammation and fibrosis via NF-κB and JAK2-STAT3 signaling pathways. J Ethnopharmacol. 207:174–183. 2017. View Article : Google Scholar : PubMed/NCBI
57	Qiu Z, He Y, Ming H, Lei S, Leng Y and Xia ZY: Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019:81518362019. View Article : Google Scholar : PubMed/NCBI
58	Beutler B, Milsark IW and Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. J Immunol. 181:7–9. 2008.PubMed/NCBI
59	Gao XL, Li JQ, Dong YT, Cheng EJ, Gong JN, Qin YL, Huang YQ, Yang JJ, Wang SJ and An DD: Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model. Cytokine. 110:466–478. 2018. View Article : Google Scholar : PubMed/NCBI
60	Fadeel B, Orrenius S and Zhivotovsky B: The potential role of apoptosis in human disease. Med Princ Pract. 9:151–163. 2000. View Article : Google Scholar
61	Kong W, Kang K, Gao Y, Liu H, Meng X, Cao Y, Yang S, Liu W, Zhang J, Yu K and Zhao M: GTS-21 protected against LPS-induced sepsis myocardial injury in mice through α7nAChR. Inflammation. 41:1073–1083. 2018. View Article : Google Scholar : PubMed/NCBI
62	Wang X and Yu Y: miR-146b protect against sepsis induced mice myocardial injury through inhibition of Notch1. J Mol Histol. 49:411–417. 2018. View Article : Google Scholar : PubMed/NCBI
63	Meng YY, Liu Y, Hu ZF, Zhang Y, Ni J, Ma ZG, Liao HH, Wu QQ and Tang QZ: Sanguinarine attenuates lipopolysaccharide-induced inflammation and apoptosis by inhibiting the TLR4/NF-κB pathway in H9c2 cardiomyocytes. Curr Med Sci. 38:204–211. 2018. View Article : Google Scholar : PubMed/NCBI
64	Falck M, Osredkar D, Wood TR, Maes E, Flatebø T, Sabir H and Thoresen M: Neonatal systemic inflammation induces inflammatory reactions and brain apoptosis in a pathogen-specific manner. Neonatology. 113:212–220. 2018. View Article : Google Scholar : PubMed/NCBI
65	Mocanu MM and Yellon DM: PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol. 150:833–838. 2007. View Article : Google Scholar : PubMed/NCBI
66	Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY and Mai SJ: Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway. Oncotarget. 7:13634–13650. 2016. View Article : Google Scholar : PubMed/NCBI
67	Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ: MicroRNA expression profiling in human ovarian cancer: miR-335 induces cell survival and cisplatin resistance by targeting PTEN MicroRNA expression profiling in human ovarian cancer: miR-335 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI